Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Nov 20;16(11):e74108.
doi: 10.7759/cureus.74108. eCollection 2024 Nov.

Neonatal Late-Onset Sepsis Due to Acinetobacter baumannii: A Case Report

Affiliations
Case Reports

Neonatal Late-Onset Sepsis Due to Acinetobacter baumannii: A Case Report

Marta Oliveira Martins et al. Cureus. .

Abstract

Late-onset sepsis (LOS) is commonly associated with pathogens acquired in hospital or community settings and carries a significant risk of morbidity and mortality in neonates. We present a case of a late preterm neonate, born at 36 weeks and 2 days with low birth weight (1700 g), who was admitted to the neonatal intensive care unit (NICU) and developed LOS on the fourth day of life. LOS was diagnosed in the context of fever and lethargy, mild thrombocytopenia, leukopenia, and lymphopenia, and was caused by multidrug-resistant (MDR) Acinetobacter baumannii, confirmed through blood culture. Initial empirical treatment with vancomycin and gentamicin was adjusted to gentamicin and meropenem based on the antibiogram, resulting in a swift and favorable clinical and laboratory response. This case, a rare occurrence in our NICU, provides an opportunity to discuss the etiology, risk factors, and clinical presentation of LOS related to Acinetobacter baumannii, as well as to highlight the growing concern of MDR microorganisms in the NICU setting.

Keywords: late onset neonatal sepsis; mdr acinetobacter baumannii; multi-drug resistance; neonatal intensive care unit; acinetobacter baumannii.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Similar articles

References

    1. Neonatal sepsis. Shane AL, Sánchez PJ, Stoll BJ. Lancet. 2017;390:0–80. - PubMed
    1. Neonatal sepsis. Ershad M, Mostafa A, Dela Cruz M, Vearrier D. Curr Emerg Hosp Med Rep. 2019;7:83–90. - PMC - PubMed
    1. Acinetobacter spp. in neonatal sepsis: an urgent global threat. Pillay K, Ray-Chaudhuri A, O’Brien S, Heath P, Sharland M. Front Antibiot. 2024;3
    1. Acinetobacter septicemia in neonates admitted to intensive care units. Shete VB, Ghadage DP, Muley VA, Bhore AV. J Lab Physicians. 2009;1:73–76. - PMC - PubMed
    1. Acinetobacter infections in neonates. Zarrilli R, Bagattini M, Esposito EP, Triassi M. Curr Infect Dis Rep. 2018;20:48. - PubMed

Publication types

LinkOut - more resources